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Abstract 
The 2019 novel coronavirus (2019-nCoV) is currently causing a widespread outbreak centered on 
Hubei province, China and is a major public health concern. Taxonomically 2019-nCoV is closely 
related to SARS-CoV and SARS-related bat coronaviruses, and it appears to share a common 
receptor with SARS-CoV (ACE-2). Here, we perform structural modeling of the 2019-nCoV spike 
glycoprotein. Our data provide support for the similar receptor utilization between 2019-nCoV 
and SARS-CoV, despite a relatively low amino acid similarity in the receptor binding module. 
Compared to SARS-CoV, we identify an extended structural loop containing basic amino acids at 
the interface of the receptor binding (S1) and fusion (S2) domains, which we predict to be 
 2 
proteolytically-sensitive. We suggest this loop confers fusion activation and entry properties 
more in line with MERS-CoV and other coronaviruses, and that the presence of this structural 
loop in 2019-nCoV may affect virus stability and transmission. 
 
Introduction 
Coronaviruses are zoonotic pathogens that are well known to evolve environmentally and infect 
many mammalian and avian species (Menachery et al., 2017). These diverse viruses often have 
effective transmission and immune evasion strategies, especially when outbreaks occur within 
dense human populations. In the past two decades, coronavirus outbreaks have arisen in human 
populations around the world, each unique but also with similarities. Severe acute respiratory 
syndrome coronavirus (SARS-CoV) emerged in 2002 in Guangdong province, China causing an 
outbreak that spread to 26 countries, with more than 8,000 infections and 774 deaths and a case 
fatality rate of 9.5% (WHO, 2004). More recently, the ongoing Middle East respiratory syndrome 
coronavirus (MERS-CoV) outbreak that originated in 2012 in Saudi Arabia has spread to 27 
countries with 2,494 infections and 858 deaths, with a case fatality rate of 34.4% (WHO, 2019). 
The recent surfacing of the novel coronavirus 2019-nCoV (first identified on December 12th, 2019) 
was initially detected in Wuhan, Hubei Province, China, and as of January 30th, 2020 has spread 
globally via travelers and has breached the boundaries of 29 countries (Lu et al., 2020). There has 
been a quarantine on Wuhan, China since January 23 -24th, 2020, along with travel restrictions 
between China and the rest of the world, in an attempt to prevent a global pandemic (Zhou et 
al., 2020a). Within the 33 provinces of China, as of January 30th, 2020 there have been more than 
9,000 suspected cases, with more than 5,900 confirmed cases and 106 fatalities as of January 
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28th, 2020 with a case fatality rate of 2-3% (Lu et al., 2020). However, the number of cases and 
deaths have been increasing daily since the outbreak started, and at the time this manuscript 
was submitted (Feb 9th, 2020), 37,592 cases and 814 fatalities have been reported (Johns Hopkins 
University, 2019). Similar to SARS-CoV and MERS-CoV, 2019-nCoV infections were observed in 
family clusters and hospital personnel (Chan et al., 2020; Gralinski and Menachery, 2020; Lu et 
al., 2020; Phan et al., 2020). The outbreak occurring during the winter is another commonality 
between SARS-CoV and 2019-nCoV (Zhou et al., 2020a).  
 
Clinical signs associated with 2019-nCoV include pneumonia, fever, dry cough, headache and 
dyspnea which may progress to respiratory failure and death (Gralinski and Menachery, 2020; 
Huang et al., 2020; Zhou et al., 2020a). The incubation period for 2019-nCoV seems to be longer 
than for SARS-CoV and MERS-CoV, which have a mean incubation time of 5 to 7 days leading to 
challenges in contact tracing (Wu et al., 2020). Preexisting conditions and comorbidities such as 
hypertension, diabetes, cardiovascular disease or kidney disease affect the severity of 
pathogenesis attributed to SARS-CoV and MERS-CoV, and thus far similar patterns seem to exist 
with 2019-nCoV (Gralinski and Menachery, 2020; Huang et al., 2020). SARS-CoV and MERS-CoV 
seem to exhibit deleterious morbidity and mortality on the elderly population (>60 years of age), 
with 26 deaths in this age group, and 2019-nCoV is currently portraying a comparable trend 
(Gralinski and Menachery, 2020).  In a study of the first 425 patients in Wuhan, China, the median 
age of the patients was 59 years; there were no cases in children less than 15 years of age and 
only a single report of a positive RT-PCR test on sputum in an asymptomatic 10 year old male 
within a family cluster infection (Chan et al., 2020).  
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The coronaviruses belong to the Coronaviridae family and the Orthocoronaviridae subfamily, 
which is divided in four genera; Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and 
Deltacoronavirus. SARS-CoV, MERS-CoV, and 2019-nCoV are all betacoronaviruses, a genus that 
includes many viruses that infect humans, bats, and other wild animals (ICTV, 2018). 
Betacoronaviruses have many similarities within the ORF1ab polyprotein and most structural 
proteins, however, the spike protein and accessory proteins portray significant diversity (Cui et 
al., 2019). MERS-CoV has maintained a stable genome since its emergence in 2012, unlike other 
coronaviruses that readily evolve and can undergo notable recombination events (Perlman, 
2020).  
 
Alphacoronaviruses and betacoronaviruses have mostly been thought to have originated in bats; 
this includes SARS-CoV, MERS-CoV and 2019-nCoV, as well as other human coronaviruses such 
as HCoV-NL63 (Cui et al., 2019; Huynh et al., 2012; Perlman, 2020). Gammacoronaviruses and 
deltacoronaviruses are reported to have an avian origin, but are known to infect both mammals 
and avian species (Woo et al., 2012).  Human infections of bat-origin viruses typically occur 
through intermediate hosts; for SARS-CoV these hosts are palm civets (Paguma larvata) and 
racoon dogs (Nyctereutes procyonoides), and for MERS-CoV the known host is the dromedary 
camel (Camelus dromedarius) (Cui et al., 2019; Xu et al., 2009). SARS-CoV antibodies were first 
detected in palm civets and the animal handlers in wet markets (Cui et al., 2019). MERS-CoV is 
thought to have been circulating for at least 30 years within the dromedary camel population 
based on retrospective antibody testing of serum from 1983 (Cui et al., 2019). The source of the 
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2019-nCoV outbreak has been reported to be linked to the Huanan seafood wholesale market in 
Wuhan, where the CDC confirmed that 43 (22%) of the 198 cases had visited the market (Li et al., 
2020). The market sells many species including seafood, birds, snakes, marmots and bats 
(Gralinski and Menachery, 2020). The market was closed on January 1st, 2020 and sampling and 
decontamination have occurred in order to find the source of the infection. Origination of 2019-
nCoV from bats has been strongly supported, but the presumed intermediate host remain to be 
identified; initial reports that 2019-nCoV had an origin in snakes have not been verified (Gralinski 
and Menachery, 2020; Zhou et al., 2020a). 
 
The coronavirus spike protein (S) is the primary determinant of viral tropism and is responsible 
for receptor binding and membrane fusion. It is a large (approx. 180 kDa) glycoprotein that is 
present on the viral surface as a prominent trimer, and it is composed of two domains, S1 and S2 
(Belouzard et al., 2012). The S1 domain mediates receptor binding, and is divided into two sub-
domains, with the N-terminal domain often binding sialic acid and the C-domain binding a specific 
proteinaceous receptor (Hulswit et al., 2016). The receptor for SARS-CoV has been identified as 
angiotensin converting enzyme 2 (ACE2), similar to what has been recently identified with 2019-
nCoV (Cui et al., 2019; Hoffmann et al., 2020; Zhou et al., 2020a). HeLa cells expressing or not 
human, Chinese horseshoe bat, mouse, civet, and pig ACE2 were infected and 2019-nCoV was 
able to use all receptors except mouse ACE2 (Zhou et al., 2020a). 2019-nCoV was also found not 
to use dipeptidyl peptidase 4 (DPP4), the receptor for MERS-CoV (Cui et al., 2019; Hoffmann et 
al., 2020; Zhou et al., 2020a). Following receptor binding, the S2 domain mediates viral-
membrane fusion through the exposure of a highly conserved fusion peptide (Lai et al., 2017; 
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Madu et al., 2009). The fusion peptide is activated through proteolytic cleavage at a site 
immediately upstream (S2’), which is common to all coronaviruses. In many (but not all) 
coronaviruses, additional proteolytic priming occurs at a second site located at the interface of 
the S1 and S2 domains (S1/S2) (Millet and Whittaker, 2015). The use of proteases in priming and 
activation, combined with receptor binding and ionic interactions (e.g. H+ and Ca2+) together 
control viral stability and transmission, and also control the conformational changes in the S 
protein that dictate the viral entry process into host cells (Belouzard et al., 2012; Heald-Sargent 
and Gallagher, 2012; Lai et al., 2017). Specifically, SARS-CoV and MERS-CoV both infect type II 
pneumocytes in vivo, however they individually infect ciliated bronchial epithelial cells and non-
ciliated bronchial epithelial cells receptively (Cui et al., 2019). Similar to SARS-CoV and MERS-CoV, 
2019-nCoV can infect ex vivo with the same range of cell culture lines, e.g. Vero E6, Huh-7 cells 
(Hoffmann et al., 2020). However primary human airway epithelial cells have been reported to 
be the preferential cell type for 2019-nCoV (Perlman, 2020; Zhu et al., 2020). Overall, how cell 
tropism of 2019-nCoV reflects a balance of receptor binding, endosomal environment and 
protease activation, and the specifics of this mechanisms remain to be determined. 
 
The rapid dissemination and sharing of information during the 2019-nCoV outbreak has 
surpassed that of both MERS-CoV or SARS-CoV, where the latter virus was only identified after 
several months and with a genome available a month later (Gralinski and Menachery, 2020). The 
2019-nCoV was identified and a genome sequence was available within a month from the initial 
surfacing of the agent in patients (Gralinski and Menachery, 2020). Initial reports identified that 
2019-nCoV contains six major open reading frames in the viral genome and various accessory 
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proteins (Zhou et al., 2020a). The SARS-like virus Bat-CoV RaTG13 was observed to have highly 
homologous conservation of the genome, with two other bat SARS-like viruses (Bat-SL-CoVZC45 
and Bat-SL-CoVZXC21) having 89-97% sequence identity (Gralinski and Menachery, 2020). The S 
protein of 2019-nCoV was found to be approximately 75% homologous to the SARS-CoV spike 
(Gralinski and Menachery, 2020; Zhou et al., 2020a). 
 
In this study, we perform bioinformatic analyses and homology structural modeling of 2019-nCoV 
S, in comparison with closely related viruses. We identify a small structural loop at the S1/S2 
interface that contains a short insert containing two arginine residues for 2019-nCoV S. These 
features are missing from all other SARS-CoV-related viruses, but present in MERS-CoV S and in 
many other coronaviruses. We discuss the importance of this extended basic loop for S protein-
mediated membrane fusion and its implications for viral transmission. 
 
Results 
Comparison of amino acid identity of the spike (S) protein of 2019-nCoV with human SARS-CoV 
To obtain an initial assessment of shared and/or specific features of the 2019-nCoV spike (S) 
envelope glycoprotein, a protein sequence alignment was performed to compare the sequence 
of the Wuhan-Hu-1 strain of the novel coronavirus with that of the closely related human SARS-
CoV S strain Tor2 sequence (Supplementary Fig. 1). The overall percent protein sequence identity 
found by the alignment was 76% (Fig. 1A). A breakdown of the functional domains of the S 
protein, based on the SARS-CoV S sequence, reveals that the S1 receptor-binding domain was 
less conserved (64% identity) than the S2 fusion domain (90% identity). Within S1, the N-terminal 
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domain (NTD) was found to be less conserved (51% identity) compared to the receptor binding 
domain (RBD, 74% identity). The relatively high degree of sequence identity for the RBD is 
consistent with the view that 2019-nCoV, like SARS-CoV, may use ACE2 as its host cell receptor, 
as for SARS-CoV (Hoffmann et al., 2020; Wan et al., 2020; Zhou et al., 2020a). Interestingly, when 
the more defined receptor binding motif (RBM) was analyzed (i.e. the region of SARS-CoV S 
containing residues that were shown to directly contact the ACE2 receptor) the identity between 
the two sequences drops to 50%, in this case hinting at possible differences in binding residues 
involved in the interaction with the receptor and/or binding affinities (Li et al., 2005; Wan et al., 
2020). As expected, within the well-conserved S2 domain, subdomain identities were high for the 
fusion peptide region (FP, 93% identity), high for the heptad-repeat 1 region (HR1, 88% identity), 
identical for HR2 (100% identity) and high for both the transmembrane and the C-terminal 
endodomain (TM, 93% identity and E, 97% identity). 
 
Phylogenetic analysis of 2019-nCoV S with other betacoronaviruses 
Early phylogenetic studies on 2019-nCoV genomic sequences revealed that it clustered closely 
with sequences originating from SARS-like sequences from bats, within lineage B of the 
Betacoronavirus genus. Lineage A groups prototypical coronaviruses such as murine hepatitis 
virus (MHV) and human coronaviruses HCoV-HKU1 and HCoV-OC43 (Fig. 1B). The other highly 
pathogenic coronavirus, MERS-CoV is found within lineage C, along with related camel-derived 
MERS-CoV. Lineage C also groups viruses from bats and other mammals such as hedgehogs. 
Lineage D contains viral species infecting bats. To gain a better understanding of both shared and 
specific features of 2019-nCoV S protein, a phylogenetic analysis centered on S protein sequences 
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of representatives of the four Betacoronavirus lineages was carried out (Fig. 1B). Fifteen 
sequences of 2019-nCoV S sequences obtained from NCBI and GISAID from China and various 
export locations world-wide were analyzed along with representative members of lineages A-D 
betacoronaviruses. The analysis confirmed that all 2019-nCoV S sequences clustered very closely 
with bat SARS-like sequences, with the closest matching sequence corresponding to a bat 
coronavirus (bat-CoV) strain named Bat-SL-RaTG13. Other closely related sequences found were 
from Bat-SL-CoVZC45 and Bat-SL-CoVZXC21. The sub-clade that groups 2019-nCoV, Bat-SL-
RaTG13, Bat-SL-CoVZC45 and Bat-SL-CoVZXC21 is distinct from the one grouping human and civet 
SARS-CoV along with other related bat SARS-like viruses, such as Bat-SL-LYRa3. 
 
Alignments of RBD and cleavage sites of 2019-nCoV and other bat-CoVs 
An S protein sequence alignment focusing on the RBD region of 2019-nCoV, SARS-CoV and bat-
SARS-related viruses reveals that the N-terminal half of the RBD is relatively well conserved 
whereas the C-terminal half, which contains the RBM, exhibits more variations (Fig. 2A). Notably, 
Bat-SL-CovZC45 and Bat-SLCoVZXC2 both have two deletions of 5 and 14 residues within the RBD. 
The composition of residues found at the two known coronavirus S cleavage sites was performed 
using alignment data (Fig. 2B and C). The region around arginine 667 (R667) of SARS-CoV S, the 
S1/S2 cleavage site aligned well with 2019-nCoV and the bat SARS-related sequences (Belouzard 
et al., 2009). Notably, an arginine at the position corresponding to SARS-CoV R667 is conserved 
for the other five sequences analyzed. The alignment shows that 2019-nCoV contains a four 
amino acid insertion 681PRRA684 that is not found in any other sequences, including the closely 
related bat-SL-RaTG13 (Fig. 2B). Together with the conserved R685 amino acid found in 2019-
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nCoV at the putative S1/S2 cleavage site, the insertion introduces a stretch of three basic arginine 
residues that could potentially be recognized by members of the pro-protein convertase family 
of proteases (Seidah, 2011; Seidah et al., 2013). This insertion was conserved for all fifteen 2019-
nCoV sequences analyzed (Supplementary Fig. 2). Within the Betacoronavirus genus, the 
presence of a basic stretch of residues at the S1/S2 site is found for a number of species from 
lineages A (HCoV-HKU1, MHV, HCoV-OC43) and C (MERS-CoV, BatCoV-HKU5). The four amino 
acid insertion feature appears unique among lineage B viruses, as all other species analyzed in 
the extended alignment, none contained the stretch of basic residues identified in 2019-nCoV S 
(Supplementary Fig. 2). As expected from previous analyses, the S2’ cleavage site, located 
immediately upstream of the fusion peptide and corresponding to the residue position R797 in 
the case of SARS-CoV, was strictly conserved for 2019-nCoV and closely related bat SARS-related 
sequences (Fig. 2C). Of note, the leucine (L) residue found at position 792 of the SARS-CoV 
sequence is substituted to serine (S) residue for 2019-nCoV S as well as the bat SARS-related 
sequences. The fusion peptide sequence was found to be well conserved for all sequences 
analyzed. 
 
2019-nCoV S protein homology structure modeling 
To gain a deeper understanding of common and possibly distinguishing features found in 2019-
nCoV S protein, homology structure modeling was undertaken. The analysis of modeled proteins 
provides a powerful tool to identify predicted structural characteristics, that can translate into 
structure-function changes in of the studied protein. Our laboratory has taken advantage of these 
tools in the past, for structure-function studies of other CoVs S proteins (Belouzard et al., 2012; 
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Jaimes et al., 2020; Jaimes and Whittaker, 2018). To perform the modeling, it is first necessary to 
identify the protein structure to be used as template, which will determine the accuracy of the 
predicted model. The S protein structure of several CoVs including: Alphacoronavirus: HCoV-NL63 
and feline coronavirus UU4 (FCoV-UU4); Betacoronavirus: HCoV-HKU1, MHV, SARS-CoV and 
MERS-CoV; Gammacoronavirus: infectious bronchitis virus (IBV); and Deltacoronavirus: porcine 
deltacoronavirus (PDCoV) have been reported previously (Kirchdoerfer et al., 2016; Shang et al., 
2018; Shang et al., 2017; Walls et al., 2016a; Walls et al., 2016b; Yang et al., 2020; Yuan et al., 
2017). Considering that genome and S protein alignments have showed that the 2019-nCoV 
belongs to the Betacoronavirus genus, we focused our analysis on the S structures from viruses 
belonging to this genus. To select the template structure, the S protein amino acid sequences 
from four representative betacoronaviruses (HCoV-HKU1, MHV, SARS-CoV and MERS-CoV) were 
aligned and the solved S protein structures were compared to determine their amino acid identity 
and the overall structural organization similarities among these proteins (Supplementary Fig. 3A). 
We observed an average of ~30% identity among the four viral S proteins at the amino acid level, 
with the exception of HCoV-HKU1 and MHV which share an amino acid identity of 59% at the S 
protein (Supplementary Fig. 3A). Despite the differences at the amino acid level, the overall 
structure of the four Betacoronavirus S proteins showed a similar folding pattern (Supplementary 
Fig. 3B), and major differences can only be spotted at specific sections of the functional domains 
where flexible loops are abundant (e.g. RBD and cleavage sites). Considering this, we built a first 
set of models for the 2019-nCoV S protein based on each of the above-mentioned structures 
(Supplementary Fig. 4). Interestingly, we found no major differences at the secondary structures 
among the 2019-nCoV S protein predicted models depending on the S structure that was used as 
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template for the modeling construction. However, extended flexible loops at the RBD and/or 
clashes between S monomers at the S2 domain level were observed in the 2019-nCoV S models 
based on HCoV-HKU1, MHV and MERS-CoV (Supplementary Fig. 4 – first three panels). In 
contrast, the predicted 2019-nCoV S model based on the SARS-CoV S structure displayed a much 
better organized folding and no major clashes were observed between the S monomers 
(Supplementary Fig. 4 – last panel). 
 
As we described previously, the identity between 2019-nCoV and SARS-CoV at the S protein 
amino acid level was 76%, and the phylogenetic analysis grouped the 2019-nCoV in the lineage A 
of the Betacoronavirus genus, closely relating to SARS-CoV, as well as to other CoVs originated in 
bats (Fig. 1B). These two considerations, in addition to our preliminary modeling results, 
suggested SARS-CoV S as the most suitable template for modeling the 2019-nCoV S protein. 
Taking an alternative approach, the S protein sequence of 2019-nCoV was submitted to two 
structure homology modeling servers (Phyre 2 
http://www.sbg.bio.ic.ac.uk/~phyre2/html/page.cgi?id=index and RaptorX 
http://raptorx.uchicago.edu). For both cases the structural models with highest homology scores 
were based on the SARS-CoV S template structure (PDB ID 5X58, data not shown), confirming the 
choice of using SARS-CoV S as template for generating structural models of 2019-nCoV. 
 
To better compare the predicted structural characteristics of the 2019-nCoV, we also performed 
homology modeling of four S proteins from Bat-CoVs belonging to lineage B in our phylogenetic 
analysis, that showed to be closely related to 2019-nCoV. The modeled S proteins from the Bat-
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CoV: RaTG13, CoVZC45, CoVZXC21 and LYRa3 were compared to the predicted structure of 2019-
nCoV S and to the template structure od SARS-CoV (Fig. 3). The amino acid homology of the 
modeled S proteins in comparison to the template SARS-CoV S was ~71% for all the Bat-CoV S 
with the exception of the LYRa3 S which shares a homology of 84.69% with the template S. 
Overall, all the modeled S proteins shared a similar folding pattern in comparison to SARS-CoV S 
and both, S1 and S2 domains showed a uniform organization (Fig. 3). As expected, differences 
were mostly observed at the flexible loops forming the ‘head” of the S1 domain, specially at the 
NTD region (RBD region), were most of the amino acid variation was observed (Fig. 2A and 3). 
The S protein amino acid identity among the Bat-CoV (including 2019-nCoV) ranged between 
75.33 – 96.65%, being the RaTG13 and the LYRa3 S proteins the ones with the highest and the 
lowest identity to 2019-nCoV, respectively. Despite amino acid variability, no major changes in 
the secondary structures and the overall folding of the proteins were observed among the 
modeled S structures of these viruses, suggesting a conserved organization for all the S proteins 
of the lineage B including the 2019-nCoV. Nevertheless, differences at the flexible loops in both 
domains were observed, and their impact in the 2019-nCoV S protein function must be further 
studied. 
 
Structural modeling of the predicted RBM 2019-nCoV  
It was recently reported that the 2019-nCoV has the potential to bind ACE2 as a receptor to infect 
the target cell (Hoffmann et al., 2020). This finding appears to agree with previous reports 
describing the ability of bat-CoVs to successfully bind and use ACE2 as a cellular receptor for 
infection (Ge et al., 2013; Menachery et al., 2016; Yang et al., 2015). This conservation in the 
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receptor usage among SARS-CoV and SARS-like bat-CoVs, contrasts with the high variability that 
we observed at the amino acid sequence of the RBM (Fig. 2A). Considering the high variability 
observed at the amino acid level of this functional region, we compared the predicted RBM 
structure of the 2019-nCoV and bat-CoVs to the one of SARS-CoV. Interestingly, despite the 
variability the modeled 2019-nCoV predicted RBM displayed a similar organization to SARS-CoV 
(Fig. 4 – top panel). This was also observed in the RaTG3 and LYRa3 predicted RBM structures 
(Fig. 4 – middle left and bottom right panels), suggesting that the RBM organization is well 
conserved among these viruses. In contrast, the predicted RBM of the CoVZC45 and CoVZXC21 
viruses showed a different folding at this region in comparison to SARS-CoV (Fig. 4 – middle right 
and bottom left panels). These two last viruses showed a 5 and, a 14 amino acid deletions at the 
RBM sequence (Fig. 2A), which can explain the differential folding in the modeled proteins. 
 
Structural modeling of 2019-nCoV S reveals a proteolytically-sensitive loop 
Figure 2B shows a four amino acid insertion 681PRRA684, as well as a conserved R685 at the S1/S2 
site of the 2019-nCoV. This insertion, which appears to be common among the lineage B of 
betacoronaviruses, suggests a differential mechanism of activation for the 2019-nCoV compared 
to other SARS-CoV and SARS-like Bat-CoV. At the structural level, the S1/S2 site has been shown 
to be difficult to solve for most CoVs structures, resulting in either incomplete structures (missing 
the complete S1/S2 site) or structures with an altered (i.e. mutated) S1/S2 site (Walls et al., 
2016a; Yang et al., 2020; Yuan et al., 2017). Solving the structure of the S1/S2 site was also found 
to be an issue in the SARS-CoV S structure we used for our modeling analyses. We have previously 
shown that the S1/S2 site can be modeled in other CoV S proteins and it appears to organize as 
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a flexible exposed loop that extends from the S structure and suggest it could be easily accessible 
for proteolytic activation (Jaimes et al., 2020). 
 
To better study the S1/S2 site structural organization, we modeled the SARS-CoV S protein based 
on the S structure of MHV (S1/S2 site mutated in the structure), and MERS-CoV and SARS-CoV 
(S1/S2 site missing in the structure) to see if the predicted structure of the S1/S2 site was similar 
in despite the template structure. We observed no differences in the modeled SARS-CoV S 
protein at the S1/S2 site, predicting an exposed flexible loop in all the three models (data not 
shown). Based on this, we proceeded to compare the S1/S2 site, as well as other major functional 
elements of the S2 domain (i.e. S2’ site and fusion peptide), in the predicted structure in our 
SARS-CoV, 2019-nCoV and Bat-CoV S models (Fig 5). Remarkably,  two features appear to exhibit 
distinctive characteristics in the 2019-nCoV S model: the fusion peptide, which is predicted to be 
organized in a more compact conformation for 2019-nCoV S than in SARS-CoV S (Fig 5 – surface 
models) and the region corresponding to the S1/S2 cleavage site which contains R667 in the case 
of SARS-CoV (Fig. 5 – S1/S2 alignment box and ribbon models). For SARS-CoV and the bat-CoV 
proteins, the S1/S2 site forms a short loop that appears flanking closely to the side of the trimeric 
structure. In the case of 2019-nCoV S, the S1/S2 site is predicted to form an extended loop that 
protrudes to the exterior of the trimer (Fig. 5). This feature suggests that the S1/S2 loop in 2019-
nCoV S could be more exposed for proteolytic processing by host cell proteases. As mentioned 
before, solving structure of the S1/S2 site appears to present difficulties for most of the reported 
CoV S structures (Fig. 6 – top panel). However, the exposed loop feature has been demonstrated 
in both modeled and cryo-EM CoV S structures with similar amino acid sequences at the S1/S2 
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site (i.e. FCoV and IBV, respectively) (Fig. 6 – top panel). Interestingly, FCoV viruses do not always 
display a S1/S2 site (Fig. 6 – top panel), which results in distinct cell entry mechanisms. We also 
performed an analysis of the S2’ site of the 2019-nCoV in comparison to SARS-CoV and bat-CoV 
S proteins. As expected, differences in the modeled S2’ site structure were not predicted in any 
of the studied spikes (Fig. 5 – S2’ ribbon models). This agrees with the fact that the S2’ site 
appears to be conserved in the studied sequences (Fig. 5 – S2’ alignment box) and as we 
described previously, the SARS-CoV functional R797 residue at the cleavage position 1 (P1). as 
well as the serine at position 798 (cleavage position P1’) are conserved in the 2019-nCoV and 
among the compared bat-CoVs. This feature also appears to be conserved in other CoVs (Fig. 6 – 
bottom panel), however, mutations in the residues immediately upstream the SARS-CoV R797 
residue (or equivalent in each virus), have been shown to result in changes in the proteolytical 
requirements in other CoVs (Millet and Whittaker, 2015). We observed mutations L to S and T to 
S, which were located upstream the P1 arginine at positions P3 and P6 in the S2’ site of the 2019-
nCoV in comparison to SARS-CoV. These mutations were not predicted to alter the structure of 
the S2’ in the 2019-nCoV (Fig. 5 – S2’ ribbon models). 
 
Discussion 
In this study, we show the presence of a distinct insert in the S1/S2 priming loop of 2019-nCoV S, 
which is not shared with SARS-CoV or any SARS-related viruses. The significance of this is yet to 
be explored experimentally, but we consider it may fundamentally change the entry pathway of 
2019-nCoV compared to other known viruses in Betacoronavirus lineage B. The presence of the 
extended S1/S2 priming loop containing paired basic residues predicts that 2019-nCoV S would 
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most likely be cleaved during virus assembly and delivery to the cell surface by Golgi-resident 
proprotein convertases such as furin. Indeed, analysis of Western blots of VSV-pseudoparticles 
containing 2019-nCoV S have shown the presence of cleaved S, in contrast to pseudoparticles 
containing SARS-CoV S (Hoffmann et al., 2020). In the case of MERS-CoV, but not SARS-CoV, it is 
known that priming of S by “pre-cleavage” occurs at the S1/S2 site, giving 2019-nCoV cleavage 
activation properties more in line with MERS-CoV than SARS-CoV (Belouzard et al., 2009; 
Hoffmann et al., 2020; Kleine-Weber et al., 2018; Millet and Whittaker, 2014). 2019-nCoV is 
currently believed to be highly SARS-CoV like with respect to its receptor binding, and the 
modeling studies reported here are broadly in line with this finding, despite the relatively low 
amino acid identity in the RBM. However it is important to remember that changes in protease 
usage may allow coronaviruses to undergo receptor-independent entry (virus-cell fusion) as well 
as affect syncytia formation (cell-cell fusion) and tissue pathology (Gallagher et al., 1992; 
Menachery et al., 2019; Phillips et al., 2017). 
 
To our knowledge, the enlarged priming loop of 2019-nCov is unique among the viruses in 
Betacoronavirus lineage C. The presence of a distinct insert containing paired basic residues in 
the S1/S2 priming loop is common in many coronaviruses in Betacoronavirus lineage C (e.g. 
MERS-CoV), as well as in lineage A (e.g. mouse hepatitis virus, MHV) and lineage d, and is 
universally found in Gammacoronavirus S (e.g. IBV) (Shang et al., 2018). It is noticeably absent in 
most Alphacoronaviruses, with the clear exception of type I canine and feline coronaviruses 
(Jaimes et al., 2020; Millet and Whittaker, 2015). One feature of the distinct insert for of 2019-
nCoV that warrants attention relates to potential changes as the virus evolves. An equivalent 
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loop is present in influenza HA (in this case adjacent to the fusion peptide), and insertions of basic 
residues into the loop are a primary marker of conversion from low pathogencity to highly 
pathogenic avian influenza virus (e.g. H5N1) (Chen et al., 1998). In coronaviruses, such loop 
modifications are known to affect MHV pathogenesis, and modulate neurovirulence and 
neuroinvasiveness of HCoV-OC43 (Frana et al., 1985; Le Coupanec et al., 2015).  The FCoV is 
another example where S1/S2 loop modifications appear to lead directly to changes in viral 
pathogenesis (André et al., 2019; Jaimes et al., 2020; Licitra et al., 2013). 
 
At present 2019-nCoV is behaving in a distinct manner compared to SARS-CoV. We believe our 
findings are of special importance considering that the available data suggests ACE2 as a suitable 
cellular receptor for 2019-nCoV entry (Huang and Herrmann, 2020; Letko and Munster, 2020). In 
our modeling analysis, we observed that the RBM of the 2019-nCoV predicted a similar 
organization as SARS-CoV and that deletions at this RBM region in other bat-CoVs are reported 
to not impact its ability to bind ACE2 (Ge et al., 2013; Menachery et al., 2016; Yang et al., 2015).  
This suggests that instead of receptor binding, the S1/S2 loop is a distinctive feature relevant to 
2019-nCoV pathogenesis and marks a unique similarity to MERS-CoV. We would predict that 
distinct insert in 2019-nCoV S would give the virus biological properties more in line with MERS-
CoV and not SARS-CoV, especially with regard to its cell entry pathway. However, it may also 
impact virus spread and transmission. While many epidemiological features of 2019-nCoV still 
need to be resolved, there are many features of transmission that align more with MERS-CoV 
then SARS-CoV. The reproductive number (R0) of 2019-nCoV (approx. 3-4), is higher than SARS-
CoV (approx. 2-3) and while MERS-CoV has a low R0 in humans (<1), it is high in camels and in 
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outbreak situations (>3) (Choi et al., 2018; Dighe et al., 2019; Lipsitch et al., 2003; Liu et al., 2020; 
Zhou et al., 2020b). One notable feature of the S protein S1/S2 cleavage site was first observed 
during the purification of the MHV S protein for structural analysis (Walls et al., 2016a). MHV 
with an intact cleavage loop was unstable when expressed, and so we consider that the S1/S2 
loop controls virus stability, likely via access to the down-stream S2’ site that regulates fusion 
peptide exposure and activity. As such it will interesting to monitor the effects of S1/S2 loop 
insertions and proteolytic cleavability in the context of virus transmission, in addition to virus 
entry and pathogenesis. 
 
Materials and methods: 
Sequences: 
Amino acid sequences of the S protein used in the phylogenetic analysis were obtained from 
GISAID and NCBI GenBank. GISAID accession numbers (in parenthesis) from which whole genome 
sequences were obtained were: 2019-nCoV-Foshan-EPI_ISL_406535 (EPI_ISL_406535), 2019-
nCoV-Foshan-EPI-ISL-406534 (EPI-ISL-406534), 2019-nCoV-France-EPI_ISL_406596 
(EPI_ISL_406596), 2019-nCoV-Guangdong-EPI_ISL_406538 (EPI_ISL_406538), 2019-nCoV-
Guangzhou-EPI_ISL_406533 (EPI_ISL_406533), 2019-nCoV-Nonthaburi-EPI_ISL_403962 
(EPI_ISL_403962), 2019-nCoV-Shenzhen-EPI_ISL_405839  (EPI_ISL_405839), 2019-nCoV-Taiwan-
EPI_ISL_406031 (EPI_ISL_406031),  2019-nCoV-USA-AZ1-ISL_406223 (EPI_ISL_406223), 2019-
nCoV-USA-CA1-ISL_406034 (EPI_ISL_406034), 2019-nCoV-USA-IL1-EPI_ISL_404253 
(EPI_ISL_404253), 2019-nCoV-USA-WA1-EPI_ISL_404895 (EPI_ISL_404895), 2019-nCoV-Wuhan-
WIV06-EPI_ISL_402129 (EPI_ISL_402129), 2019-nCoV-Zhejiang-EPI_ISL_404228 
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(EPI_ISL_404228), Bat-SL-RaTG13 (EPI_ISL_402131). GenBank accession numbers (in 
parenthesis) from which whole genome or S gene sequences were obtained were: 2019-nCoV-
Wuhan-Hu1 (MN908947.3), Bat-SL-CoVZC45 (MG772933.1), Bat-SL-CoVZXC21 (MG772934.1), 
Bat-SL-LYRa3 (KF569997.1), BatCoV/133 (DQ648794.1), BatCoV-GCCDC1 (NC_030886.1), 
BatCoV-HKU4-1 (EF065505.1), BatCoV-HKU5-1 (EF065509.1), BatCoV-HKU9 (NC_009021.1), 
BatCoV-Neo/PML-PHE1/RSA (KC869678.4), BatCoV-SC2013 (KC869678.4), Bat-CoV-BM48-31 
(NC_014470.1), Bat-SL-HKU3-1 (DQ022305.2), Bat-SL-LYRa11 (KF569996.1), Bat-SL-Rf1 
(DQ412042.1), Bat-SL-Rs4231 (KY417146.1), Bat-SL-Rs4255 (KY417149.1), Bat-SL-Rs4874 
(KY417150.1), Bat-SL-RS672 (FJ588686.1), Bat-SL-WIV1 (KC881007.1), BtRs-BetaCoV/YN2018C 
(MK211377.1), BtRs-BetaCoV/YN2018D (MK211378.1), camMERS-CoV-HKFU-HKU-13 
(KJ650295.1), camMERS-CoV-HKU23 (KF906251.1), camMERS-CoV-KSA-505 (KJ713295.1), 
camMERS-CoV-NRCE-HKU205 (KJ477102.1), camMERS-CoV-NRCE-HKU270 (KJ477103.2), 
CivSARS-CoV-SZ3 (P59594.1), HCoV-229E (NC_002645.1), HCoV-HKU1 (AY597011.2), HCoV-OC43 
(KF963244.1), Hedgehog-CoV/VMC/DEU (KC545383.1), hMERS-CoV-EMC/2012 (JX869059.2), 
hMERS-CoV-England-1 (KC164505.2), hMERS-CoV-Jordan-N3 (KC776174.1), hSARS-CoV-BJ01 
(AY278488.2), hSARS-CoV-GZ02 (AY390556.1), hSARS-CoV-HKU39849 (JN854286.1), hSARS-CoV-
Tor2 (NC_004718.3), MHV-A59 (M18379.1). 
 
For S protein modeling, amino acid sequences of SARS-CoV Urbani (AAP13441.1), 2019-nCoV-
Wuhan-Hu1 (MN908947.3), , Bat-SL-CoVZC45 (MG772933.1), Bat-SL-CoVZXC21 (MG772934.1), 
Bat-SL-LYRa3 (KF569997.1) and FCoV WSU-79-1683 (JN634064.1) were obtained from the NCBI 
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GenBank, and Bat-SL-RaTG13 (EPI_ISL_402131) was obtained from GISAID data base. Amino acid 
sequence of the FCoV-TN406 S was provided by Prof. Susan Baker (Loyola University Chicago). 
 
Amino acid alignments and phylogenetic trees: 
Sequences alignments were performed on coronavirus S protein sequences using MAFFT v7.388 
(Katoh et al., 2002; Katoh and Standley, 2013). A Maximum-Likelihood phylogenetic tree based 
on the S protein alignment was generated using PhyML (Guindon et al., 2010). Numbers at nodes 
indicate bootstrap support (100 bootstraps). Sequence alignment display and formatting was 
performed using Geneious R10 (Biomatters) and phylogenetic tree display and formatting was 
performed using FigTree 1.4.3 (http://tree.bio.ed.ac.uk/). 
 
S protein modeling: 
Beta-CoV S protein structures and amino acid sequences were obtained from the RCSB Protein 
Data Base: HCoV-HKU1 (PDB# 5I08), MHV (PDB# 3JCL), MERS-CoV (PDB# 6Q05), SARS-CoV (PDB# 
5X58), FCoV-UU4 (PDB# 6JX7), IBV-M41 (PDB# 6CV0) and HCoV-NL63 (PDB# 5SZS). Pairwise 
amino acid alignments between each of the Beta-CoV and the 2019-nCoV were performed using 
Geneious Prime® (v.2019.2.3. Biomatters Ltd.) and exported as *.FASTA file extension for further 
application. S protein models were built using UCSF Chimera (v.1.14, University of California) 
through modeler homology tool of the Modeller extension (v.9.23, University of California) and 
edited using PyMOL (v.2.0.7, Schrodinger LLC.). 2019-nCoV S models built was based on HCoV-
HKU1, MHV, MERS-CoV and SARS-CoV S structures. Models for the Bat-CoV RaTG13, Bat-CoV 
CoVZC45, Bat-CoV CoVZXC21, Bat-CoV LYRa3 and SARS-CoV were built based on SARS-CoV S 
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structure. Finally, FCoV-TN406 and FCoV WSU-78-1683 S models were built based on HCoV-NL63 
S structure. Additional SARS-CoV S models based on MHV and MERS-CoV S structures were built 
to validate our modeling approach (data not shown). 
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Figure 1. Comparative analyses of 2019-nCoV S protein sequence. A. Protein sequence identities 
between 2019-nCoV S with SARS-CoV S. The S protein sequences were aligned and the sequence 
identities obtained for the full-length and domains/subdomains are shown on the S protein 
diagram. Amino acid delineations of domains and subdomains are based on the SARS-CoV S 
protein. B. Phylogenetic analysis of 2019-nCoV S protein. The S protein sequence of 15 isolates 
of 2019-nCoV were aligned with representatives of all four Betacoronavirus lineages. A 
Maximum-Likelihood tree was generated based on the alignment. The tree was rooted using the 
alphacoronavirus HCoV-229E S sequence. Number at nodes indicate bootstrap support (100 
replicates). Accession numbers of sequences used in the analyses are found in the methods 
section. 
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Figure 2. Sequence alignments of S protein regions of 2019-nCoV with closely related species. 
S protein sequences from 2019-nCoV, SARS-CoV, and closely related bat coronaviruses, bat-SL-
RaTG13, bat-SL-CoVZC45, bat-SL-CoVZXC21, bat-SL-LYRa3 were aligned. The regions 
corresponding to the receptor binding domain (RBD, A.), the S1/S2 cleavage site (red arrow, B.) 
and S2’ cleavage site (red arrow, C.) are shown. RBM: receptor binding motif. Accession numbers 
of sequences used in the analyses are found in the methods section. 
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Figure 3. 2019-nCoV and bat-CoVs S protein models. The modeled S protein of 2019-nCoV, 
RaTG13, CoVZC45, CoVCZXC21 and LYRa3 are compared to SARS-CoV S structure. The amino acid 
homology between the modeled proteins and SARS-CoV S is noted in red and amino acid 
differences in blue in both models and identity scale. The S amino acid identity between 2019-
nCoV and bat-CoVs is also noted (black identity scale). 
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Figure 4. 2019-nCoV and bat-CoVs modeled RBM. Surface view of SARS-CoV S structure and 
2019-nCoV, RaTG13, CoVZC45, CoVCZXC21 and LYRa3 S models. SARS-CoV RBM (red) and 
flanking residues (yellow) are noted. RBM in the modeled structures is also noted according to 
their amino acid homology (red) and differences (blue) to SARS-CoV. 
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Figure 5. 2019-nCoV S1//S2 and S2’ activation sites. The S1/S2 and S2’ activation sites of SARS-
CoV and 2019-nCoV S models are shown in surface and ribbon views. S1/S2 and S2’ sites of bat-
CoVs are shown in ribbon view. Amino acid homology to SARS-CoV is noted as follows: S1/S2 site: 
homology (red) and differences (blue); S2’ site: homology (yellow) and differences (magenta). 
Amino acid alignments of the S1/S2 and S2’ sites are shown, and homology is also noted. 
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Figure 6. CoVs S1/S2 and S2’ site. The S1/S2 and S2’ activation sites of FCoV, MERS-CoV and IBV. 
S models are shown ribbon views. Amino acid homology to SARS-CoV is noted as follows: S1/S2 
site: homology (red) and differences (blue); S2’ site: homology (yellow) and differences 
(magenta). Amino acid sequences of the S1/S2 and S2’ sites are shown. 
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Supplementary figure 1. Sequence alignment of the S protein of 2019-nCoV with SARS-CoV. The 
sequences of the S proteins of 2019-nCoV and SARS-CoV were aligned and the full-length 
alignment is shown. Accession numbers of sequences used in the analysis are found in the 
methods section. 
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Supplementary figure 2. Sequence alignment of the S1/S2 region of 2019-nCoV with
 
representatives of betacoronavirus lineages. The S protein sequence of 15 isolates of 2019-nCoV 
were aligned with representatives of all four Betacoronavirus lineages (lineages are denoted by 
the letters A, B, C, and D). The sequence for the Alphacoronavirus HCoV-229E is also included in 
the alignment. Displayed is the region corresponding to the S1/S2 cleavage site. Red border 
indicates the insert of basic arginines identified for 2019-nCoV sequences.  α: Alphacoronavirus; 
β: Betacoronavirus. Accession numbers of sequences used in the analyses are found in the 
methods section. 
 
 
 35 
 
 
Supplementary figure 3. Betacoronavirus S protein structures. A. Amino acid identity table 
between Betacoronavirus S proteins. B. Betacoronavirus S protein structures: HCoV-HKU1, MHV, 
MERS-CoV and SARS-CoV. 
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Supplementary figure 4. 2019-nCoV S protein models based on Betacoronavirus structures. The 
2019-nCoV S protein models were built based on the structure of HCoV-HKU1, MHV, MERS-CoV 
and SARS-CoV. The amino acid homology (red) and differences (blue) are noted. Amino acid 
identity scale is also shown. 
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